Translational Approaches for Human Liver Disease

Translational Approaches for Human Liver Disease

Tuesday, February 20, 2018

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

 

Non-alcoholic steatohepatitis (NASH) is the second leading cause of disease driving the need for liver transplantation in the United States with no approved treatments currently available. While a number of clinical approaches are under investigation, historically many promising drug candidates have not demonstrated clinical benefit, in part due to an over-reliance on animal models.

In vitro approaches that incorporate primary human cell types to model disease have the potential to improve clinical success by bridging the gap from preclinical animal models to patients. This symposium will present cutting-edge research highlighting current and emerging in vitro model systems, covering potential benefits and limitations for the treatment of liver disease.

Poster abstract deadline

Friday December 15, 2017

Registration

Member
$60
Nonmember Academia, Faculty, etc.
$105
Nonmember Corporate, Other
$160
Nonmember Not for Profit
$105
Nonmember Student, Undergrad, Grad, Fellow
$70
Member Student, Post-Doc, Fellow
$25

Scientific Organizing Committee

Translational Approaches for Human Liver Disease
John Broadwater, PhD, Boehringer Ingelheim
Translational Approaches for Human Liver Disease
Scott Friedman, MD, Icahn School of Medicine at Mount Sinai
Translational Approaches for Human Liver Disease
John Hambor, PhD, Boehringer Ingelheim
Translational Approaches for Human Liver Disease
Joel Lavine, MD PhD, Columbia University
Translational Approaches for Human Liver Disease
Claire Steppan, PhD, Pfizer
Translational Approaches for Human Liver Disease
Gregory Tesz, PhD, Pfizer
Translational Approaches for Human Liver Disease
Sonya Dougal, PhD, The New York Academy of Sciences

Speakers

Translational Approaches for Human Liver Disease
Ernesto Guccione, PhD, Icahn School of Medicine at Mount Sinai
Translational Approaches for Human Liver Disease
Paulina Ordonez, MD, University of California San Diego
Translational Approaches for Human Liver Disease
Brian Wamhoff, PhD, HemoShear Therapeutics
Translational Approaches for Human Liver Disease
Leah M. Norona, PhD, University of North Carolina, Chapel Hill
Translational Approaches for Human Liver Disease
Tracy C. Grikscheit, MD, Keck School of Medicine, USC

Premier Supporter

Silver Sponsors

Regeneron

Academy Friend

American Chemical Society New York Chapter